SRPT logo

Sarepta Therapeutics (SRPT) Operating expenses

annual operating expenses:

$1.36B+$3.98M(+0.29%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual total operating expenses is $1.36 billion, with the most recent change of +$3.98 million (+0.29%) on December 31, 2024.
  • During the last 3 years, SRPT annual operating expenses has risen by +$310.25 million (+29.42%).
  • SRPT annual operating expenses is now at all-time high.

Performance

SRPT Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

quarterly operating expenses:

$907.68M+$543.25M(+149.07%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly total operating expenses is $907.68 million, with the most recent change of +$543.25 million (+149.07%) on March 1, 2025.
  • Over the past year, SRPT quarterly operating expenses has increased by +$579.68 million (+176.73%).
  • SRPT quarterly operating expenses is now at all-time high.

Performance

SRPT quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

SRPT Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.3%+176.7%
3 y3 years+29.4%+240.9%
5 y5 years+61.2%+314.3%

SRPT Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+29.4%at high+240.9%
5 y5-yearat high+61.2%at high+352.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

SRPT Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$907.68M(+149.1%)
Dec 2024
$1.36B(+0.3%)
$364.43M(+3.2%)
Sep 2024
-
$353.29M(+10.7%)
Jun 2024
-
$319.09M(-2.7%)
Mar 2024
-
$328.00M(+0.0%)
Dec 2023
$1.36B(+2.4%)
$327.98M(+3.9%)
Sep 2023
-
$315.63M(-12.5%)
Jun 2023
-
$360.63M(+1.1%)
Mar 2023
-
$356.57M(+6.6%)
Dec 2022
$1.33B(+26.0%)
$334.46M(+4.0%)
Sep 2022
-
$321.67M(-20.9%)
Jun 2022
-
$406.82M(+52.8%)
Mar 2022
-
$266.27M(-3.4%)
Dec 2021
$1.05B(+1.3%)
$275.53M(+37.5%)
Sep 2021
-
$200.42M(-35.8%)
Jun 2021
-
$312.15M(+17.2%)
Mar 2021
-
$266.45M(-9.2%)
Dec 2020
$1.04B(+23.0%)
$293.45M(+10.3%)
Sep 2020
-
$265.98M(+1.4%)
Jun 2020
-
$262.38M(+19.8%)
Mar 2020
-
$219.08M(-28.1%)
Dec 2019
$846.57M(+38.7%)
$304.76M(+45.4%)
Sep 2019
-
$209.59M(+15.9%)
Jun 2019
-
$180.88M(+19.5%)
Mar 2019
-
$151.34M(-27.4%)
Dec 2018
$610.47M(+110.2%)
$208.42M(+49.0%)
Sep 2018
-
$139.84M(-18.9%)
Jun 2018
-
$172.44M(+92.1%)
Mar 2018
-
$89.76M(+13.0%)
Dec 2017
$290.44M(+7.8%)
$79.47M(+25.7%)
Sep 2017
-
$63.20M(-31.7%)
Jun 2017
-
$92.58M(+67.2%)
Mar 2017
-
$55.36M(-39.7%)
Dec 2016
$269.50M(+21.7%)
$91.81M(+62.4%)
Sep 2016
-
$56.53M(-8.8%)
Jun 2016
-
$61.98M(+3.8%)
Mar 2016
-
$59.70M(-9.1%)
Dec 2015
$221.44M(+54.3%)
$65.70M(+26.9%)
Sep 2015
-
$51.76M(+22.9%)
Jun 2015
-
$42.11M(-31.9%)
Mar 2015
-
$61.86M(+38.2%)
Dec 2014
$143.55M(+37.4%)
$44.75M(+28.8%)
Sep 2014
-
$34.73M(+5.7%)
Jun 2014
-
$32.85M(+5.3%)
Mar 2014
-
$31.21M(-12.0%)
Dec 2013
$104.50M(+55.9%)
$35.48M(+21.9%)
Sep 2013
-
$29.10M(+45.2%)
Jun 2013
-
$20.04M(+0.7%)
Mar 2013
-
$19.89M(+12.3%)
Dec 2012
$67.03M(-19.2%)
$17.70M(+22.3%)
Sep 2012
-
$14.48M(-13.6%)
Jun 2012
-
$16.76M(-7.3%)
Mar 2012
-
$18.09M(-19.9%)
Dec 2011
$82.92M(+64.7%)
$22.59M(+20.2%)
Sep 2011
-
$18.80M(-13.4%)
Jun 2011
-
$21.71M(+9.5%)
Mar 2011
-
$19.83M(+14.9%)
DateAnnualQuarterly
Dec 2010
$50.35M(+52.2%)
$17.26M(+38.1%)
Sep 2010
-
$12.50M(+7.2%)
Jun 2010
-
$11.66M(+30.5%)
Mar 2010
-
$8.94M(-1.7%)
Dec 2009
$33.09M(-14.7%)
$9.10M(-1.9%)
Sep 2009
-
$9.27M(+15.8%)
Jun 2009
-
$8.01M(+19.3%)
Mar 2009
-
$6.71M(-19.8%)
Dec 2008
$38.80M(-12.0%)
$8.37M(-24.6%)
Sep 2008
-
$11.11M(+12.6%)
Jun 2008
-
$9.86M(+4.3%)
Mar 2008
-
$9.46M(-12.9%)
Dec 2007
$44.09M(+33.2%)
$10.85M(-5.0%)
Sep 2007
-
$11.43M(+2.1%)
Jun 2007
-
$11.19M(+5.4%)
Mar 2007
-
$10.62M(+20.8%)
Dec 2006
$33.10M(+48.4%)
$8.79M(+20.6%)
Sep 2006
-
$7.29M(-2.0%)
Jun 2006
-
$7.44M(-22.4%)
Mar 2006
-
$9.59M(+51.6%)
Dec 2005
$22.30M(-12.5%)
$6.32M(+21.6%)
Sep 2005
-
$5.20M(+0.2%)
Jun 2005
-
$5.19M(-7.2%)
Mar 2005
-
$5.59M(+7.0%)
Dec 2004
$25.47M(+28.4%)
$5.22M(+1.8%)
Sep 2004
-
$5.13M(-29.4%)
Jun 2004
-
$7.27M(-7.4%)
Mar 2004
-
$7.85M(+7.7%)
Dec 2003
$19.84M(-24.2%)
$7.29M(+43.2%)
Sep 2003
-
$5.09M(+37.1%)
Jun 2003
-
$3.72M(-0.6%)
Mar 2003
-
$3.74M(-13.5%)
Dec 2002
$26.18M(+62.5%)
$4.32M(-22.9%)
Sep 2002
-
$5.60M(-31.0%)
Jun 2002
-
$8.12M(-0.2%)
Mar 2002
-
$8.13M(+61.8%)
Dec 2001
$16.11M(+34.7%)
$5.03M(+37.6%)
Sep 2001
-
$3.65M(-5.7%)
Jun 2001
-
$3.87M(+8.9%)
Mar 2001
-
$3.56M(-2.8%)
Dec 2000
$11.96M(+37.4%)
$3.66M(+30.7%)
Sep 2000
-
$2.80M(-8.2%)
Jun 2000
-
$3.05M(+24.7%)
Mar 2000
-
$2.45M(-2.2%)
Dec 1999
$8.70M(+7.4%)
$2.50M(+8.7%)
Sep 1999
-
$2.30M(+15.0%)
Jun 1999
-
$2.00M(+11.1%)
Mar 1999
-
$1.80M(-30.8%)
Dec 1998
$8.10M(+80.0%)
$2.60M(+30.0%)
Sep 1998
-
$2.00M(+5.3%)
Jun 1998
-
$1.90M(+11.8%)
Mar 1998
-
$1.70M(+41.7%)
Dec 1997
$4.50M(+60.7%)
$1.20M(+20.0%)
Sep 1997
-
$1.00M(-33.3%)
Jun 1997
-
$1.50M(+87.5%)
Mar 1997
-
$800.00K
Dec 1996
$2.80M
-

FAQ

  • What is Sarepta Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual operating expenses year-on-year change?
  • What is Sarepta Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly operating expenses year-on-year change?

What is Sarepta Therapeutics annual total operating expenses?

The current annual operating expenses of SRPT is $1.36B

What is the all time high annual operating expenses for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total operating expenses is $1.36B

What is Sarepta Therapeutics annual operating expenses year-on-year change?

Over the past year, SRPT annual total operating expenses has changed by +$3.98M (+0.29%)

What is Sarepta Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of SRPT is $907.68M

What is the all time high quarterly operating expenses for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total operating expenses is $907.68M

What is Sarepta Therapeutics quarterly operating expenses year-on-year change?

Over the past year, SRPT quarterly total operating expenses has changed by +$579.68M (+176.73%)
On this page